Bunkerhill ECG-EF vs PMcardio

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by BunkerHill Health
VS
by Powerful Medical

AI Verdict

Both Bunkerhill ECG-EF and PMcardio are AI-powered tools designed to interpret ECGs for cardiac conditions, making them direct competitors. Bunkerhill ECG-EF specifically focuses on detecting reduced LVEF, aiding in early heart failure identification, while PMcardio offers a broader interpretation of over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, with additional features like AI explainability and a freemium model. The choice between them would depend on whether a user requires a specialized LVEF detection tool or a more comprehensive ECG interpretation platform.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your primary need is early, large-scale screening for reduced left ventricular ejection fraction (LVEF ≤ 40%) to identify patients at risk for heart failure. This tool is ideal for integrating into existing EHRs and clinical archives to automate workflows and flag high-risk individuals for further cardiac evaluation, especially in settings where echocardiography may not be readily available.

View Bunkerhill ECG-EF →

Choose PMcardio if…

Choose PMcardio if you require rapid, comprehensive interpretation of ECGs for over 50 cardiac conditions, including critical diagnoses like STEMI/OMI and various arrhythmias, with AI explainability. This tool is best suited for clinicians needing expert-level ECG analysis at the point of care, across various settings from emergency departments to primary care, and offers mobile accessibility and a freemium model for individual use.

View PMcardio →

For a physician evaluating AI tools for ECG interpretation, Bunkerhill ECG-EF and PMcardio offer distinct advantages. Bunkerhill ECG-EF is specifically designed and FDA-cleared to detect reduced left ventricular ejection fraction (LVEF ≤ 40%) from routine 12-lead ECGs, making it highly specialized for early identification of heart failure risk. Its integration with EHRs and focus on automated clinical workflows suggests it’s best suited for practices prioritizing a streamlined, targeted screening for LVEF within their existing systems.

In contrast, PMcardio is a broader, CE-certified AI platform that interprets ECGs for over 50 cardiac conditions, including STEMI/OMI, various rhythms, and also reduced LVEF. Its mobile app and web platform deployment, coupled with a freemium pricing model, make it highly accessible for individual clinicians seeking a comprehensive, expert-level ECG interpretation tool at the point of care. The key practical difference lies in their scope: Bunkerhill ECG-EF is a focused solution for LVEF screening, while PMcardio offers a wide array of diagnostic interpretations.

Therefore, a physician primarily concerned with efficient, integrated screening for reduced LVEF and heart failure risk within an established EHR system might favor Bunkerhill ECG-EF. Conversely, a physician desiring a versatile, accessible tool for rapid, comprehensive ECG interpretation across a wide range of cardiac conditions, potentially at the point of care or in a mobile setting, would likely find PMcardio to be the more suitable choice.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill ECG-EF PMcardio
Pricing Contact for pricing Freemium
Deployment Integrates seamlessly with EHRs and clinical archives. Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Pending AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers a mobile app and web platform, providing flexibility for individual clinicians and organizations. Its freemium model allows users to experience the tool before committing to a paid plan, enhancing accessibility and user-friendliness. Bunkerhill ECG-EF primarily focuses on EHR/EMS integration, which is great for enterprise but less accessible for individual users seeking a quick, on-the-go solution.

Clinical Value

PMcardio

PMcardio detects over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, and has been validated in more than 25 clinical studies, demonstrating superior accuracy compared to standard methods. Bunkerhill ECG-EF focuses specifically on detecting reduced LVEF and has been validated in a retrospective study involving 15,994 patient records. While both offer significant clinical value, PMcardio's broader diagnostic capabilities and extensive validation give it an edge.

Pricing & Value

PMcardio

PMcardio offers a transparent freemium model, allowing users to analyze 5 ECGs per month for free, with clear pricing for individual and team subscriptions. Bunkerhill ECG-EF requires contacting for pricing, which lacks transparency and immediate accessibility for potential users. PMcardio's tiered pricing and free option provide greater flexibility and value for a wider range of users.

Enterprise Readiness

PMcardio

Both tools offer enterprise integrations with EHR/EMS systems. However, PMcardio's established use by over 100,000 clinicians and its comprehensive platform for organizations, including unlimited ECG capacity and advanced dashboards, suggest a more mature and proven enterprise solution. Bunkerhill ECG-EF integrates seamlessly with EHRs and clinical archives and is part of the Carebricks platform, but specific enterprise adoption metrics are not as readily available.

Innovation

PMcardio

PMcardio demonstrates greater innovation with its detection of 50+ ECG findings, visual AI explainability (ECGxplainu2122 with heatmaps), and features like Culprit Artery AI confidence scores with 3D heart visualization. Bunkerhill ECG-EF, while innovative in its FDA-cleared LVEF detection from ECGs, has a more focused application. PMcardio's continuous updates and new modules also highlight a strong commitment to ongoing innovation.

Support & Docs

PMcardio

PMcardio provides a comprehensive 'Resources' section on its website, including a blog, regulatory information, security details, a help center, and FAQs, indicating robust support and documentation. While Bunkerhill Health offers integration and is part of the Carebricks platform, specific details about their public-facing support and documentation are not as extensively detailed in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill ECG-EF PMcardio
Tool Name Bunkerhill ECG-EF PMcardio
Company BunkerHill Health Powerful Medical
Tagline Generative AI for clinical reasoning and action. AI that reads ECGs in seconds
Key Detections Reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) 50+ cardiac conditions (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders)
Regulatory Clearance FDA-cleared CE-certified

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill ECG-EF integrates seamlessly with EHRs and clinical archives as a software-only medical device, and is part of the Carebricks platform which can automate next steps like notifying care teams or routing referrals. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, and can connect to existing ECG systems and communication tools, designed to fit into current workflows and scale across multiple sites.
Bunkerhill ECG-EF demonstrated a sensitivity of 82.66% and a specificity of 83.20% for detecting LVEF u2264 40% in a diverse patient population. PMcardio has been clinically validated in over 25 studies, showing 86% sensitivity and 92% specificity for major ECG abnormalities, and 97% sensitivity and 99% specificity for Atrial Fibrillation. PMcardio's Queen of Hearts platform for STEMI detection showed 92% sensitivity and 81% specificity compared to standard processes.
Bunkerhill ECG-EF specifically focuses on detecting reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) to aid in early heart failure identification. PMcardio is a more comprehensive platform, capable of detecting over 50 cardiac conditions, including various rhythms and arrhythmias (e.g., Atrial Fibrillation/flutter, tachycardias), conduction disorders (e.g., bundle-branch blocks, AV blocks), and ischemia/infarction (e.g., STEMI, OMI).
PMcardio is designed for speed, simplicity, and clinical confidence, with an intuitive mobile app and web platform that can digitize any 12-lead ECG from a photo or screenshot. It aims to provide expert-level interpretations rapidly, empowering various healthcare professionals. Bunkerhill ECG-EF is integrated into the Carebricks platform, which is designed to automate workflows and surface insights, suggesting a focus on streamlining existing processes rather than requiring extensive new interpretation skills.
Bunkerhill Health's Carebricks platform allows health systems to create tailored, AI-powered workflows and automate next steps, implying comprehensive implementation support. PMcardio offers enterprise-ready deployment with a single integration and security review, and provides clinical suites that cover the full spectrum of cardiac care, suggesting robust organizational support.
Bunkerhill ECG-EF is available through the MyoVista Insights platform, which is designed to be device-agnostic and accessible to healthcare facilities of all sizes, from large integrated health systems to primary care practices. PMcardio for Organizations is a unified cardiac AI platform built for multi-pathway, multi-site cardiac care delivery, connecting to existing systems and scaling across campuses and care settings without custom builds.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.